Prelude Capital Management’s Akari Therapeutics AKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-12
Closed -$15K 1762
2014
Q3
$15K Buy
12
+2
+20% +$2.5K ﹤0.01% 1644
2014
Q2
$12K Buy
+10
New +$12K ﹤0.01% 1628